Aleigha R Lawless

5PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Dec 12, 2025
Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

|Dec 04, 2025
Real-World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations.

Derek Effiom, Tyler Aprati, Anastasios Karneris

|Sep 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapy.

Jung-Ho Chun, Birkley S Lim, Suyasha Roy

|Jan 09, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.

Yi Sun, Luke Maggs, Apekshya Panda

Pageof 1

Frequent Collaborators

3 joint publications

Genevieve M Boland

3 joint publications

Russell W Jenkins

3 joint publications

Ryan Sullivan

2 joint publications

Arnav Mehta